SCHEMBL9535070

SCHEMBL9535070

CCC(=O)n1c(C=O)c(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 5/20 0.37
GP6 Q9HCN6 1/20 0.37
AGTR1 P30556 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9553927 0.94 AGTR2 (0.38) AGTR2GP6AGTR1
SCHEMBL9554025 0.92 GP6 (0.40) AGTR2GP6AGTR1
SCHEMBL9553731 0.92 AGTR2 (0.36) AGTR2GP6AGTR1
SCHEMBL9530732 0.92 AGTR2 (0.42) AGTR2GP6AGTR1
SCHEMBL9554695 0.90 GP6 (0.45) AGTR2GP6AGTR1
SCHEMBL9553977 0.90 AGTR2 (0.38) AGTR2GP6AGTR1
SCHEMBL9532776 0.90 AGTR1 (0.37) AGTR2AGTR1
SCHEMBL9532745 0.90 AGTR1 (0.37) AGTR2AGTR1
SCHEMBL9554167 0.89 AGTR1 (0.38) AGTR2AGTR1
SCHEMBL9534328 0.89 AGTR1 (0.36) AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575614-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-12-29 EP claimed
WO-1992016526-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-10-01 WO claimed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed